OXFORD, England, April 18, 2023 (GLOBE NEWSWIRE) -- Owen Mumford is proud to have been awarded a distinction in the prestigious Red Dot awards for innovative product design for its Aidaptus single-use ...

Stevanato Group (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology ...

Industry first single-use auto-injector for both 1ml and 2.25 pre-filled syringes with versatile design for different fill volumes in the same device. Aidaptus has an innovative, patient-centric ...

Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range ...

The Aidaptus ® disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...

Highest level of recognition for ground-breaking design as Aidaptus auto-injector receives distinction in Red Dot award. OXFORD, England, 18 April 2023 - Owen Mumford is proud to have been awarded a ...

Highest level of recognition for ground-breaking design as Aidaptus auto-injector receives distinction in Red Dot award OXFORD, England, April 18, 2023 (GLOBE NEWSWIRE) -- Owen Mumford is proud to ...

The Aidaptus disposable auto-injector platform, designed by Owen Mumford, will be jointly offered to global biopharma companies to support their drug development programs with engineering and ...